Summary: Berra Yazar-Klosinski, Ph.D., of MAPS and MAPS Public Benefit Corporation (MAPS PBC) joins Northstar Sleep School’s podcast to share progress updates about MAPS’ research and consider …
Phase 2 clinical trial will compare the safety and efficacy of self-titrated high-THC cannabis against placebo for treatment of PTSD among Veterans Second clinical trial of inhaled botanical cannabis is …
Summary: Pharmacy Times interviews Bia Labate, Ph.D., of MAPS and Chacruna Institute and psychiatric pharmacist Kelan Thomas, Pharm.D., M.S., about the significant scale of current clinical trials involving …
Summary: Listen to MAPS Founder and Executive Director Rick Doblin, Ph.D., on The Recount’s Hell & High Water podcast, where he and John Heilemann discuss exciting developments in the field …
Summary: Listen to MAPS Founder and Executive Director Rick Doblin, Ph.D., on the Drug Science Podcast, where he speaks with Professor David Nutt about MAPS’ 35-year history, current project updates, …
Ismail L. Ali, J.D., of MAPS joins other drug policy reform experts in assessing President Joe Biden’s drug policy plans in Lucid News. In addition to drawing parallels between progress in “broader …
Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., and Bia Labate, Ph.D., MAPS Public Education and Culture Specialist and Chacruna Institute Executive Director, provided compelling arguments …
*|MC:SUBJECT|* *|MC_PREVIEW_TEXT|* Today is Our 35th Anniversary! Launching our new logo and a new video Today is the 35th anniversary of the Multidisciplinary Association for Psychedelic Studies (MAPS)! …
Psychedelic Science 2021 Webinar Series presented by the Multidisciplinary Association for Psychedelic Studies (MAPS) In this multidisciplinary online course, we’ll explore the latest advancements …
In February, New Jersey reduced criminal penalties for possession of up to an ounce of psilocybin, as well as legalized cannabis. The MAPS Policy and Advocacy team has been working closely with California …
Summary: Rick Doblin, Ph.D., MAPS Founder and Executive Director, explains the history, stigma, pharmacology, and therapeutic potential of MDMA on the Mind Medicine Australia Podcast. “Based on this …
Summary: TED Radio Hour on NPR welcomes MAPS Founder Rick Doblin, Ph.D., for a discussion with Manoush Zomorodi about clinical research into treating mental health conditions with psychedelic-assisted …
